Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Parathyroid hormone/parathyroid hormone-related peptide receptor | ||
Ligand | BDBM50600479 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2234293 (CHEMBL5148065) | ||
IC50 | 40±n/a nM | ||
Citation | Arai, Y; Kiyotsuka, Y; Nagamochi, M; Oyama, K; Izumi, M Lead optimization of pyrido[2,3-d][1]benzazepin-6-one derivatives leading to the discovery of a potent, selective, and orally available human parathyroid hormone receptor 1 (hPTHR1) antagonist (DS69910557). Bioorg Med Chem64:0 (2022) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Parathyroid hormone/parathyroid hormone-related peptide receptor | |||
Name: | Parathyroid hormone/parathyroid hormone-related peptide receptor | ||
Synonyms: | PTH/PTHr receptor | PTH/PTHrP type I receptor | PTH1 receptor | PTH1R | PTH1R_HUMAN | PTHR | PTHR1 | Parathyroid hormone 1 receptor | Parathyroid hormone receptor | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 66370.95 | ||
Organism: | Homo sapiens (Human) | ||
Description: | PARATHYROID HT1 0 HUMAN::Q03431 | ||
Residue: | 593 | ||
Sequence: |
| ||
BDBM50600479 | |||
n/a | |||
Name | BDBM50600479 | ||
Synonyms: | CHEMBL5171680 | ||
Type | Small organic molecule | ||
Emp. Form. | C32H34Cl2N4O3 | ||
Mol. Mass. | 593.543 | ||
SMILES | CC1(C)c2ncc(Cl)cc2-c2ccc(Cl)cc2N(c2ccc(cc2)N2CC(CN[C@H]3CC[C@H](CC3)C(O)=O)C2)C1=O |r,wU:29.31,32.38,(3.5,-4,;2.01,-3.61,;3.1,-2.52,;1.35,-5,;2.4,-6.12,;1.96,-7.6,;.46,-7.96,;.06,-9.45,;-.6,-6.84,;-.16,-5.35,;-1.38,-4.39,;-2.7,-5.16,;-4.04,-4.4,;-4.04,-2.85,;-5.37,-2.08,;-2.71,-2.08,;-1.38,-2.85,;-.18,-1.89,;-.58,-.4,;-2.06,0,;-2.46,1.48,;-1.37,2.57,;.11,2.18,;.52,.7,;-1.77,4.06,;-1,5.4,;-2.36,6.18,;-2.75,7.67,;-1.67,8.75,;-.18,8.36,;.91,9.45,;2.4,9.05,;2.8,7.56,;1.71,6.47,;.22,6.87,;4.28,7.16,;5.37,8.25,;4.68,5.67,;-3.13,4.84,;1.32,-2.21,;2.41,-1.13,)| | ||
Structure |